Introduction {#s1}
============

Genomic medicine (GM) is anticipated to profoundly affect medical practice. Primary care providers (PCPs), as first contact with the health care system and key to continuous and coordinated care, will be critical to the effective and appropriate implementation of GM. In studies over a decade ago, PCPs described how they would play an increasing role in GM. Essential skills identified by PCPs at that time included taking a family history, assessing genetic risk, providing a gatekeeping function by deciding who is appropriate for referral to genetics, providing patient support and coordinating surveillance and management.([@B23]; [@B10]) Over the subsequent years, integration of GM into clinical practice, including primary care, has been slow. A key reason for this is the lack of evidence of clinical utility of many genetic tests, but barriers and challenges to primary care implementation also include concern about the ethical, legal, and social implications of genetic testing, lack of PCP knowledge and skills, systems issues (e.g. time), and lack of awareness of genetic services. ([@B19]; [@B40]) PCPs and genetics experts acknowledge that PCPs need more knowledge in the area of genomics.([@B23]; [@B10]; [@B51]; [@B29]; [@B14]). Recognizing that a disease might be hereditary, indications for genetics referral and benefits and limitations of genetic tests ranked highest in a study of educational needs for general practitioners by a heterogeneous panel of experts.([@B30]) Core competencies in GM for health professionals have been developed.([@B51]; [@B35]) There is agreement that strategies to enable the appropriate integration of GM into primary care require more than merely addressing a knowledge deficit, but must also address attitudes and propose new systems of care to facilitate practice. These proposed "roadmaps" include training and education but also innovative systemic changes such as integration of genomic results into the electronic health record (EHR) with clinical decision support, and new models of delivering genetic services such as genetic counselors or nurses embedded in primary care clinics or made available through telephone helplines, etc. ([@B1]; [@B37]; [@B31]; [@B18])

Preparing PCPs for GM first requires an assessment of their educational needs, in order to provide clear and purposeful direction and to justify educational activities. Little is known about what role PCPs see for themselves in the rapidly changing landscape of GM including pharmacogenomics, direct-to-consumer genetic testing and whole genome sequencing, or what system changes they think might be helpful and would be willing to incorporate in their practices. Our objectives were to determine family physicians' (FP) current involvement in GM, confidence in GM primary care competencies, attitudes regarding the clinical importance of GM, awareness of genetic services, resources required, and suggestions for changes that would enable integration of GM into practice.

Materials and Methods {#s2}
=====================

Questionnaire Design and Administration {#s2_1}
---------------------------------------

This study used a self-complete, anonymous questionnaire which was developed by a multidisciplinary team. Where possible, questions were derived from the literature or previous questionnaires. ([@B11]; [@B12]) The questionnaire was divided into eight sections: current role and confidence in the tasks of each role providing genetic services in their practices (14 questions), completion of family history (2 questions), attitudes toward GM (11 questions), awareness of and experience with genetic services (12 questions), knowledge (18 questions), education and resources required (37 questions), and demographics (18 questions). Answers were a mixture of 3--5 point Likert scales (confidence, attitudes, awareness, resources), yes/no (experience), and multiple choice (knowledge). The knowledge component of the questionnaire consisted of 10 clinical vignettes with an accompanying question (4 cancer; 1 inheritance; 2 prenatal; 1 pediatric; 1 consanguinity; 1 adult onset disorder). One question asked "What would help you integrate genomic medicine into your practice in the future?" Several options were listed that were derived from the literature ([@B1]) as well as the research team, with a box to add "other" suggestions. Questions were pilot tested for face and content validity with 20 FPs from three practices.

In the body of the questionnaire we defined genomics as "the study of genes, their function and their interaction with all the other genes in the genome and the environment." GM was defined as medicine that "uses genomic information and technologies (e.g. DNA sequencing) to determine an individual's risk, predisposition, diagnosis and prognosis, and the selection and prioritization of therapeutic options (e.g. pharmacogenetic testing prior to administration of certain medications)."

The study was conducted from September 2012 to April 2013. Questionnaires were mailed to a random sample of 2,000 Ontario FPs taken from Scott's Directory of Canadian physicians. A modified Dillman Method was employed ([@B20]) including an introductory letter, questionnaire package 1 week later with instructions for a web link if preferred for questionnaire completion, a postcard reminder/thank you 2 weeks following the questionnaire, a second questionnaire package to non-responders 4 weeks following the postcard, and final mailed reminder 8 weeks later. As a token of appreciation, once a completed questionnaire was received, the respondent was entered into a draw to win one of twenty \$150 Amazon Canada gift cards. FPs were considered eligible if they were in active full-time or part-time practice of family medicine in Ontario, Canada. Ethics approval was obtained from the Children's Hospital of Eastern Ontario Research Ethics Board.

Statistical Analysis {#s2_2}
--------------------

Completed questionnaires were coded, data were entered into an Excel spreadsheet, and analyzed using IBM SPSS, version 23 (IBM Corporation, Armonk, New York, USA, 2015).

Five-point Likert scales were collapsed into binary data by combining levels 4 and 5 for confidence variables as "confident" in skills, for attitudes and awareness variables as "agree/strongly agree," for interest in education variables as "moderate/high," for genetics resources as "useful/very useful." A confidence score was created from items 1--10 of [**Table 2**](#T2){ref-type="table"}. These items were chosen as they were considered current core GM skills. We did not include newer skills related to pharmacogenomics and direct-to-consumer testing. One point was given for a rating of 4 or 5 on a confidence item, with a total score of ≥5/10 items indicating a "high" confidence score. A knowledge score that was greater than 7/10 correct was categorized as "high."

Frequency distributions provided a descriptive analysis of the data. Correlation analysis was used to establish if there was an association between high knowledge and high confidence. Chi-squared analyses were conducted to look for associations between demographic variables and outcomes. Variables with significant associations were entered into binary logistic regression models to determine if they were predictors of confidence, attitudes, awareness, knowledge, and education and resources regarding GM. Covariates included in the model were older age (≤50/ \> 50 years), younger age (≤40/\> 40 years), sex (male/female), years in practice (\<15/≥15 years), practice location (urban -- population ≥ 500K/rural -- population \< 500K), practice type (solo/group or other), focused practice (yes/no), involved in teaching (yes/no), use electronic medical record (EMR) (yes/no), formal education in genetics (yes/no), continuing medical education in genetics in the last 5 years (yes/no), special interest in genetics (yes/no), and genetic condition in a close family member (yes/no).

Results {#s3}
=======

Demographics {#s3_1}
------------

In total, 2,000 surveys were mailed, of which 159 were ineligible: wrong address, not in active practice or deceased, not practicing in Ontario, or belonged to excluded specialties. Of the remaining 1841 questionnaires, 361 were returned completed, giving a raw response rate of 19.6%. A random sample of 100 of the 1,442 non-responders was contacted by the project manager (SM) to determine if they met the eligibility criteria. Of those, 33 of the 100 contacted were not eligible for the reasons listed above. We then assumed that approximately 33% of the total non-responder group would also be ineligible, giving an adjusted response rate of 26.4% (361/1,365 eligible FPs) ([**Figure 1**](#f1){ref-type="fig"}).

![Response rate flowchart.](fgene-10-01189-g001){#f1}

Demographics of respondents are shown in [**Table 1**](#T1){ref-type="table"}. Mean age was 51 years, with 53.2% male. Most (72.5%) had no formal education in genetics, but a small proportion indicated a special interest in genetics (18.3%), presence of a genetic condition in a close family member (20.7%) or had personally seen a genetic counselor or geneticist (10.6%).

###### 

Participant demographics (n = 361)\*.

  Characteristic                                                                                             Mean (SD)      Range
  ---------------------------------------------------------------------------------------------------------- -------------- -------------------
  Age                                                                                                        50.9 (11.72)   Range: 27--77 yrs
                                                                                                             **N**          **%**
  Sex: male                                                                                                  185/348        53.2
  Size of practice community ≥500,000                                                                        157/351        44.7
  Type of practice: solo                                                                                     81/350         23.1
  Focused practice \>50%                                                                                     54/338         16.0
  Involved in teaching                                                                                       192/353        54.4
  Some formal education in genetics                                                                          94/342         27.5
  Continuing education in genetics in last 5 yrs                                                             57/352         16.2
  Special interest in genetics                                                                               64/349         18.3
  Genetic condition in a close family member                                                                 72/348         20.7
  Personally seen a genetic counsel or/geneticist for concern related to personal or family health history   37/350         10.6

\*Includes all respondents including family physicians (FPs) in focused practice.

Current Role in Genomic Medicine {#s3_2}
--------------------------------

Participating FPs reported high involvement in some aspects of traditional GM (eliciting FH (93.3%)), identifying individuals with genetic conditions (89.5%), deciding who should be offered genetic referral (93.8%), knowing where to refer for genetic counseling (91.9%), and providing support to a patient coping with a genetic test result (82.8%) ([**Table 2**](#T2){ref-type="table"}). Most respondents (69.2%) reported completing a family history on 100% of new patients, with 72.6% reporting they routinely updated the family history yearly or at the periodic health exam.

###### 

Current role in delivering genomic medicine and confidence with each task\*.

  Role                                                                                                                       Part of current practice (yes)   Level of confidence with task (high = 4 or 5 on Likert scale)             
  -------------------------------------------------------------------------------------------------------------------------- -------------------------------- --------------------------------------------------------------- --------- ------
  1\. Eliciting information about genetic conditions as part of a family or medical history                                  263/282                          93.3                                                            122/277   44.0
  2\. Identifying individuals with a genetic condition                                                                       246/275                          89.5                                                            59/277    21.3
  3\. Deciding who should be offered referral for genetic counseling or testing based on personal or family health history   256/273                          93.8                                                            89/278    32.0
  4\. Knowing where to refer for genetic counseling/genetic assessment                                                       249/271                          91.9                                                            151/273   55.3
  5\. Providing support to patients coping with a genetic test result                                                        227/274                          82.8                                                            82/273    30.0
  6\. Evaluating the clinical usefulness of a genetic test                                                                   144/271                          53.1                                                            40/256    15.6
  7\. Discussing the benefits, risks, and limitations of genetic testing with patients                                       180/273                          65.9                                                            43/265    16.2
  8\. Describing what to expect at a genetic counseling session                                                              169/273                          61.9                                                            57/265    21.5
  9\. Obtaining credible, current information about genetics                                                                 134/259                          51.7                                                            25/235    10.6
  10\. Providing education about genetic conditions to patients                                                              184/272                          67.6                                                            45/265    17.0
  11\. Discussing genetic variation in drug response with patients (e.g. pharmacogenetics)                                   74/264                           28.0                                                            10/224    4.5
  12\. Discussing the risks, benefits and limitations of "Direct-to-Consumer" genomic testing with patients                  44/263                           16.7                                                            7/213     3.3
  13\. Discussing the interpretation of "Direct-to-Consumer" genomic test results with patients                              37/263                           14.1                                                            4/212     1.9
  14\. Discussing the interpretation of whole genome sequencing with patients                                                20/262                           7.6                                                             4/208     1.9

\*Includes only respondents who indicated they were not in focused practice, i.e. provided full scope family medicine.

However, reported involvement in some GM tasks was more limited with fewer than two-thirds saying that evaluating the use of a genetic test, discussing benefits, risks, and limitations of genetic testing with patients, describing what to expect at a genetic counseling session, and obtaining credible, current information about genetics were part of their current practice. Finally, involvement in emerging genomics practices such as pharmacogenetics (28.0%), direct-to-consumer genetic tests (discussing risks/benefits/limitations 16.7%, interpretation 14.1%), and whole genome sequencing (7.6%) was even more limited.

Confidence in GM Skills {#s3_3}
-----------------------

Self-reported confidence for these same GM skills was generally low ([**Table 2**](#T2){ref-type="table"}). Even for high involvement skills, confidence was moderate (ranging from 21.3% to 55.3%), while fewer than 5% agreed/strongly agreed they were confident in the emerging genomic practices listed above.

Attitudes Toward GM {#s3_4}
-------------------

More than half (203/342, 59.4%) agreed/strongly agreed that they expected advances in GM to improve patients' health outcomes and that they needed to keep up to date with advances in GM (179/343, 52.2%) and 43.1% (148/343) agreed it was important to learn about personalized patient care based on targeted or whole genome sequencing ([**Table 3**](#T3){ref-type="table"}). Fewer than half (124/342, 36.3%) agreed it was their responsibility to incorporate GM into practice or saw sufficient benefits to warrant testing for inherited adult onset disease (140/342, 40.9%). Only 15.2% (52/341) agreed or strongly agreed that genomics is an exciting part of practice. However, the majority agreed/strongly agreed that GM is going to make important contributions to the diagnosis and management of prenatal (269/342, 78.7%), pediatric (259/342, 75.7%), and adult onset conditions (215/341, 63.0%).

###### 

Attitudes toward genomic medicine.

  -----------------------------------------------------------------------------------------------------------------------------------------
  Statement                                                                                                Agreed/Strongly agreed   
  -------------------------------------------------------------------------------------------------------- ------------------------ -------
  Advances in genomic medicine will improve my patients' health outcomes                                   203/342                  59.4

  I need to keep up to date with advances in genomic medicine                                              179/343                  52.2

  Important for me to learn about personalized patient care based on targeted or whole genome sequencing   148/343                  43.1

  As a primary care provider, it is my responsibility to incorporate genomic medicine into my practice     124/342                  36.3

  There are sufficient benefits to warrant testing for inherited adult onset diseases                      140/342                  40.9

  I find genetics and genomics an exciting part of my practice                                             52/341                   15.2

  Genomic medicine is going to make important contributions to diagnosis and management of:\               \                        \
  Prenatal conditions\                                                                                     \                        \
  Pediatric conditions\                                                                                    269/342\                 78.7\
  Adult onset conditions                                                                                   259/342\                 75.7\
                                                                                                           215/341                  63.0
  -----------------------------------------------------------------------------------------------------------------------------------------

Awareness of Genetic Services {#s3_5}
-----------------------------

Very few agreed/strongly agreed that they could identify useful sources of information regarding genetics for their practice (78/349, 22.3%) or could find information about genetic tests available within the health care system (74/348, 21.3%) ([**Table 4**](#T4){ref-type="table"}). The majority however, knew where to refer for various genetic disorders (prenatal 240/255, 94.1%; newborn screening 173/216, 80.1%; pediatric 241/294, 82.0%; adult onset 247/328, 75.3%), with most having referred for prenatal genetic issues or adult onset genetic disorders (prenatal 177/253, 70.0%; newborn screening 69/210, 32.9%; pediatric 106/282, 37.6%; adult onset 236/327, 72.2%).

###### 

Awareness of genetic services.

  --------------------------------------------------------------------------------------------------------------------------------------------
  Statement                                                                                                   Agreed/Strongly agreed   
  ----------------------------------------------------------------------------------------------------------- ------------------------ -------
  I can identify useful sources of information regarding genetics for my practice                             78/349                   22.3

  I can find information about genetic tests available within healthcare system                               74/348                   21.3

                                                                                                              **Yes\***                

                                                                                                              **N**                    **%**

  Know where to refer patients for these disorders:\                                                          \                        \
  Prenatal genetic disorders Newborn screening disorders Pediatric genetic disorders\                         \                        \
  Adult onset genetic disorders                                                                               240/255\                 94.1\
                                                                                                              173/216\                 80.1\
                                                                                                              241/294\                 82.0\
                                                                                                              247/328                  75.3

  Have referred a patient to a genetics clinic for a personal or family history of any of these disorders:\   \                        \
  Prenatal genetic disorders Newborn screening disorders Pediatric genetic disorders\                         \                        \
  Adult onset genetic disorders                                                                               \                        \
                                                                                                              \                        \
                                                                                                              177/253\                 70.0\
                                                                                                              69/210\                  32.9\
                                                                                                              106/282\                 37.6\
                                                                                                              236/327                  72.2
  --------------------------------------------------------------------------------------------------------------------------------------------

\*Includes only respondents who provide care in specified areas.

Knowledge Regarding Clinical Genetic Disorders {#s3_6}
----------------------------------------------

The median knowledge score on the 10 clinical vignettes was 6/10 with a range from 0 to 10 ([**Table 5**](#T5){ref-type="table"}). On average, 31.0% indicated they were unsure of the answer.

###### 

Clinical vignettes/knowledge questions regarding clinical genetic disorders.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Vignette (correct response is bolded)                                                                                                                                                                                                                                                                                                                     Correct response   
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ ------
  1\. Suppose you had a patient whose aunt or grandmother on her father's side carried the *BRCA1* gene mutation for breast/ovarian cancer syndrome. In your opinion, could your patient also be a carrier of this mutation?\                                                                                                                               181/339            53.4
  **a.** **Yes**\                                                                                                                                                                                                                                                                                                                                                              
  b. No\                                                                                                                                                                                                                                                                                                                                                                       
  c. Not sure                                                                                                                                                                                                                                                                                                                                                                  

  2\. In your opinion, what percentage of breast cancer patients has a *BRCA1* or *BRCA2* gene mutation?\                                                                                                                                                                                                                                                   206/339            60.8
  **a.** **\< 10%**\                                                                                                                                                                                                                                                                                                                                                           
  b. 10-50%\                                                                                                                                                                                                                                                                                                                                                                   
  c. 51-100% d. Not sure                                                                                                                                                                                                                                                                                                                                                       

  3\. In your opinion, what percentage of patients who carry a gene for hereditary non-polyposis colorectal cancer will actually go on to develop colorectal cancer?\                                                                                                                                                                                       153/338            45.3
  a. \< 50%\                                                                                                                                                                                                                                                                                                                                                                   
  **b.** **≥50%**\                                                                                                                                                                                                                                                                                                                                                             
  c. Not sure                                                                                                                                                                                                                                                                                                                                                                  

  4\. A father and his son have the same inherited single gene disorder. The least likely mode of inheritance for this disorder is:\                                                                                                                                                                                                                        157/338            46.4
  **a.** **X-linked**\                                                                                                                                                                                                                                                                                                                                                         
  b. Autosomal dominant\                                                                                                                                                                                                                                                                                                                                                       
  c. Autosomal recessive\                                                                                                                                                                                                                                                                                                                                                      
  d. Not sure                                                                                                                                                                                                                                                                                                                                                                  

  5\. All of the following are absolute indications to offer a prenatal patient referral for genetic counseling EXCEPT:\                                                                                                                                                                                                                                    276/337            81.9
  a. One parent is a carrier of a balanced chromosomal rearrangement\                                                                                                                                                                                                                                                                                                          
  b. Parental consanguinity\                                                                                                                                                                                                                                                                                                                                                   
  **c.** **History of one prior pregnancy ending in miscarriage.**\                                                                                                                                                                                                                                                                                                            
  d. Family history of cystic fibrosis e. Not sure                                                                                                                                                                                                                                                                                                                             

  6\. The Society of Obstetricians and Gynaecologists of Canada recommends offering pre-conception or prenatal genetic screening for which disorder(s) to couples where only one member is of Ashkenazi Jewish descent?\                                                                                                                                    139/338            41.1
  a. Tay-Sachs disease\                                                                                                                                                                                                                                                                                                                                                        
  b. Canavan disease\                                                                                                                                                                                                                                                                                                                                                          
  c. Familial dysautonomia\                                                                                                                                                                                                                                                                                                                                                    
  **d.** **All of the above** e. Not sure                                                                                                                                                                                                                                                                                                                                      

  7\. A young boy has behavioral problems and developmental delay. Which is the least likely genetic diagnosis?\                                                                                                                                                                                                                                            194/338            57.4
  a. Williams syndrome\                                                                                                                                                                                                                                                                                                                                                        
  b. Down syndrome\                                                                                                                                                                                                                                                                                                                                                            
  c. Fragile X syndrome\                                                                                                                                                                                                                                                                                                                                                       
  **d.** **Turner syndrome** e. Not sure                                                                                                                                                                                                                                                                                                                                       

  8\. You've been monitoring a patient for a strong maternal history of colon cancer. During a routine gynecological exam, she corrects a note in her chart that a maternal aunt actually had endometrial cancer and not cervical cancer. This raises your index of suspicion to recommend genetic counseling for which hereditary colon cancer syndrome?   115/350            32.9

  a\. Familial juvenile polyposis\                                                                                                                                                                                                                                                                                                                                             
  b. Familial colitis\                                                                                                                                                                                                                                                                                                                                                         
  **c.** **HNPCC (hereditary non-polyposis colon cancer) or Lynch syndrome**\                                                                                                                                                                                                                                                                                                  
  d. FAP (familial adenomatous polyposis)\                                                                                                                                                                                                                                                                                                                                     
  e. Not sure                                                                                                                                                                                                                                                                                                                                                                  

  9\. A 29-year-old female patient informs you that her husband is her maternal first cousin. She is concerned about the risks to their future offspring. You counsel her that:\                                                                                                                                                                            103/351            29.3
  a. The chance for this couple to have a child with a congenital anomaly is about the same as population risk (2-3%)\                                                                                                                                                                                                                                                         
  b. **The chance for this couple to have child with a congenital anomaly is about double the population risk (4-6%)**\                                                                                                                                                                                                                                                        
  c. The chance for this couple to have a child with a congenital anomaly is significantly higher than the population risk (\> 10%)\                                                                                                                                                                                                                                           
  d. Not sure                                                                                                                                                                                                                                                                                                                                                                  

  10\. Please indicate which one of the following scenarios would be appropriate for referral to genetics:\                                                                                                                                                                                                                                                 250/347            72.0
  a. A patient's family history is significant for dementia in her mother. The age of onset is 72\                                                                                                                                                                                                                                                                             
  b. A patient reports a family history of dementia in her maternal grandfather in his early eighties and in her maternal aunt at age 67\                                                                                                                                                                                                                                      
  c**.** **A patient reports a family history of dementia in her paternal grandfather in his sixties and in her paternal uncle in his fifties. Her father is age 48 and in good health**\                                                                                                                                                                                      
  d. Not sure                                                                                                                                                                                                                                                                                                                                                                  
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Genetics Resources {#s3_7}
------------------

Resources "usually used" for information about genetics included Up to Date^®^ or similar internet sources, Google or Wikipedia ([**Table 6**](#T6){ref-type="table"}). Fewer than half used their local genetics clinic or local specialists. Resources that respondents indicated would be useful included local genetics clinic contact information (308/347, 88.8%), genetic referral (293/343, 85.4%), and testing (296/344, 86.0%) guidelines, information summaries for patients about genetic disorders (246/344, 71.5%) and disease-specific risk assessment tools (279/343, 81.3%). Over half (193/342, 56.4%) thought a genetics education website would be useful (results not shown). Respondents indicated their level of interest in a menu of education topics in GM listed in [**Table 7**](#T7){ref-type="table"}. More than half (205/355, 57.7%) expressed moderate to high interest in learning about new advances in genomic technologies.

###### 

Resources usually used for information about genetics^\*^.

  Resource                                                N         \%
  ------------------------------------------------------- --------- ------
  Up to Date or similar internet source                   183/346   52.9
  My local genetics clinic/genetic counselor/geneticist   166/346   48.0
  Internet search engine (e.g., Google)                   159/346   46.0
  Local specialists                                       114/343   33.2
  Wikipedia                                               72/346    20.8
  Local genetics clinic website                           50/346    14.5
  Genetests website                                       14/346    4.0

\*Includes all respondents including FPs in focused practice.

###### 

Genomics topics of interest to family physicians^\*^.

  Topic                                                                                                                                              Respondents reporting moderate or high interest   
  -------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------- ------
  Genomic risk factors for common complex diseases (e.g. cancer, heart disease, diabetes                                                             272/355                                           76.6
  Genetics services in your area                                                                                                                     267/353                                           75.6
  Genetics of common single gene disorders (e.g. cystic fibrosis, hereditary breast and ovarian cancer)                                              266/356                                           74.7
  Genetic testing (e.g. clinical utility, availability, how to order, benefits/harms, accuracy, interpretation)                                      255/355                                           71.8
  Family history (e.g. taking a multigenerational history, red flags, assessing risk, recognizing patterns of inheritance)                           249/356                                           69.9
  Basic genetic concepts (e.g. inheritance, genes, mutation, penetrance, predisposition versus diagnosis)                                            219/356                                           61.5
  New advances in genomic technologies entering clinical practice (e.g. "Direct-to-Consumer" genomic testing, whole genome sequencing, microarray)   205/355                                           57.7

\*Includes all respondents including FPs in focused practice.

Contact with a local genetic counselor by telephone/fax or email (225/339, 66.4%) or a buddy system with a geneticist being available for questions (172/339, 50.7%) were the most popular suggestions for how to integrate GM into primary care practice. Less than half wanted a visiting genetic counselor providing educational sessions (118/339, 34.8%), a FP in their clinic with a special interest in genetics (73/339, 21.5%), or a genetic counselor in the clinic seeing patients (65/339, 19.2%) (results not shown).

There was a weak positive correlation between high knowledge and high confidence (Pearson correlation coefficient r = 0.227, p \< 0.001). No demographic variables were associated with high confidence. Being age 50 or under (40.7% ≤50 vs 21.5% \> 50, p \< 0.001), female (38.2% vs 23.2% male, p = 0.005), in group practice (35.2% group vs 14.3% solo, p = 0.001), involved in teaching (36.7% teaching vs 21.7% not, p = 0.005), using an EMR (34.4% using EMR vs 16.0% not p = 0.002), having some formal genetics education (41.4% education vs 26.0% not, p = 0.009), and indicating interest in genetics (42.9% interest vs 27.7% not indicating interest, p = 0.036) were significantly associated with higher knowledge. Respondents who were involved in teaching (43.4% vs 28.1% not in teaching, p = 0.004), indicated interest in genetics (50.0% vs 33.6% not interested, p = 0.024), or had high confidence in the GM skills specified (50.9% vs 30.2% low confidence, p = 0.004), were more likely to agree/strongly agree that it was their responsibility to incorporate GM into their practices.

[**Table 8**](#T8){ref-type="table"} indicates predictors of high reported confidence in various clinical skills in GM. Participants who indicated they had an interest in genetics were twice as likely to have a high confidence score (≥5/10) (OR 2.17 95% CI 1.00--4.70, p = 0.05). Individuals who indicated an interest in genetics were also more likely to agree or strongly agree that advances in GM will improve patients' health outcomes (OR 3.18, 95% CI 1.50--6.71, p = 0.002) and that it is their responsibility to incorporate GM into practice (OR 1.93, 95% CI 1.03--3.63, p = 0.042). ([**Table 8**](#T8){ref-type="table"}) Female FPs (OR 1.90, 95% CI 1.05--3.41, p = 0.033) and those indicating an interest in genetics (OR 2.01, 95% CI 1.01--3.98, p = 0.046) were also significantly more likely to have a high knowledge score (≥7/10) ([**Table 8**](#T8){ref-type="table"}).

###### 

Confidence, attitudes, awareness, and knowledge regarding genomic medicine: significant results from binary logistic regression analysis.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome variable                                                                      Covariate                Odds ratio   Lower 95% CI   Upper 95% CI   p-value
  ------------------------------------------------------------------------------------- ------------------------ ------------ -------------- -------------- ---------
  **Confidence (high: level 4 or 5)**                                                                                                                       

  Eliciting information about genetic conditions as part of family history              Female\                  1.83\        1.09\          3.07\          0.022\
                                                                                        CE last 5 yrs            2.44         1.24           4.80           0.010

  Identifying individuals with a genetic condition                                      Interest in genetics     2.35         1.21           4.58           0.012

  Deciding who to offer genetics referral                                               Focused practice         0.38         0.17           0.88           0.024

  Knowing where to refer for genetic assessment                                         Female\                  1.69\        1.01\          2.84\          0.048\
                                                                                        Teaching\                1.69\        1.01\          2.83\          0.046\
                                                                                        CE last 5 yrs            2.36         1.17           4.73           0.016

  Providing genetics education to patients                                              Age ≤50\                 2.42\        1.02\          5.75\          0.046\
                                                                                        Female\                  0.48\        0.24\          0.99\          0.047\
                                                                                        Teaching                 2.66         1.22           5.80           0.014

  Providing support to patients with a genetic test result                              Focused\                 0.34\        0.14\          0.82\          0.016\
                                                                                        Practice CE last 5 yrs   3.14         1.59           6.21           0.001

  Discussing benefits/risks of genetic testing with patients                            CE last 5 yrs            2.47         1.09           5.57           0.030

  Obtaining credible/current info about genetics                                        CE last 5 yrs            3.00         1.06           8.48           0.038

  High confidence score (≥5/10)                                                         Focused practice\        0.29\        0.09\          0.89\          0.030\
                                                                                        Interest in genetics     2.17         1.00           4.70           0.050

  **Attitudes (agree or strongly agree)**                                                                                                                   

  Advances in genomic medicine will improve health outcomes                             Female\                  0.57\        0.33\          0.97\          0.039\
                                                                                        Interest in genetics     3.18         1.50           6.71           0.002

  Need to keep up to date with advances in genomic medicine                             Interest in genetics     3.23         1.63           6.37           0.001

  Important to learn about personalized patient care based on whole genome sequencing   Female\                  0.56\        0.33\          0.94\          0.029\
                                                                                        Use EMR\                 2.06\        1.06\          3.99\          0.033\
                                                                                        Interest in genetics     3.50         1.80           6.81           \<0.001

  My responsibility to incorporate genomic medicine into practice                       Interest in genetics     1.93         1.03           3.63           0.042

  Genetics is an exciting part of my practice                                           CE last 5 yrs\           2.32\        1.00\          5.38\          0.049\
                                                                                        Interest in genetics     4.85         2.32           10.15          \<0.001

  **Awareness (agree or strongly agree)**                                                                                                                   

  Can identify useful sources of information                                            Genetics Education\      2.44\        1.28\          4.65\          0.007\
                                                                                        Interest in genetics     1.99         1.01           3.93           0.048

  I know how to contact my local genetics centre                                        CE last 5 yrs            2.17         1.05           4.48           0.036

  **Knowledge**                                                                                                                                             

  High knowledge score (≥7/10)                                                          Female\                  1.90\        1.05\          3.41\          0.033\
                                                                                        Interest in genetics     2.01         1.01           3.98           0.046
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------

CE, continuing education in genetics in last 5 years. Genetics education, some formal education in genetics.

CI, confidence interval; EMR, electronic medical record.

Those who indicated an interest in genetics were significantly more likely to indicate moderate or high interest in almost every type of education offered ([**Table 9**](#T9){ref-type="table"}). Those who use an EMR were more likely to find various guidelines, apps, and tools useful ([**Table 9**](#T9){ref-type="table"}). We compared demographic variables of those who indicated a special interest in genetics with those who did not. The only significant difference was that 32% of those with a special interest in genetics indicated they had a genetic condition in the family compared with 18% of those with no special interest (p = 0.15).

###### 

Genomic medicine education and resources: significant results from binary logistic regression analysis.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome variable                                                               Covariate               Odds ratio   Lower 95% CI   Upper 95% CI   p-value
  ------------------------------------------------------------------------------ ----------------------- ------------ -------------- -------------- ----------
  **Education (method of learning about genetics: moderate or high interest)**                                                                      

  In person seminar, workshop, lecture                                           CE last 5 yrs\          0.46\        0.22\          0.94\          0.033\
                                                                                 Interest in genetics    2.60         1.10           6.18           0.030

  Video conferencing of seminar, workshop, lecture                               Teaching\               1.92\        1.00\          3.66\          0.049\
                                                                                 Interest in genetics    2.33         1.19           4.58           0.014

  Didactic lecture on website                                                    Interest in genetics    2.08         1.09           3.99           0.027

  Podcast                                                                        Age ≤40                 3.19         1.34           7.59           0.009

  Problem-based small group learning modules                                     Urban\                  0.58\        0.34\          0.97\          0.038\
                                                                                 Interest in genetics\   3.86\        1.88\          7.93\          \<0.001\
                                                                                 Condition in family     2.25         1.18           4.30           0.014

  Interdisciplinary learning environment                                         Age ≤40\                0.43\        0.21\          0.90\          0.024\
                                                                                 Interest in genetics    2.13         1.14           3.99           0.018

  Short observership with genetic counselor                                      Genetics education\     0.43\        0.19\          0.95\          0.037\
                                                                                 Interest in genetics    3.47         1.70           7.09           0.001

  Genetics education sessions at practice                                        Interest in genetics    2.18         1.15           4.13           0.017

  Genetics education website                                                     Teaching\               0.51\        0.30\          0.89\          0.018\
                                                                                 Interest in genetics    2.13         1.08           4.20           0.030

  **Genetics resources (useful or very useful for your practice)**                                                                                  

  Information summaries                                                          Female                  2.04         1.14           3.67           0.017

  Downloadable MP3 audioclips/lectures/podcasts                                  CE last 5 yrs           0.35         0.14           0.90           0.029

  CD ROMs                                                                        Age ≤40\                0.28\        0.12\          0.70\          0.006\
                                                                                 CE last 5 yrs           0.31         0.11           0.86           0.025

  Genetic testing guidelines                                                     Use EMR                 2.61         1.13           6.04           0.025

  Disease specific risk assessment tools                                         Use EMR                 2.14         1.00           4.59           0.050

  EMR                                                                            Use EMR                 6.32         3.18           12.57          \< 0.001

  Apps for smartphones and tablets                                               Use EMR                 2.80         1.44           5.45           0.002

  Web Widgets                                                                    Age ≤50                 3.17         1.40           7.18           0.006

  Genetics education website                                                     Focused practice\       2.82\        1.33\          5.97\          0.007\
                                                                                 Interest in genetics    2.22         1.12           4.39           0.022
  ------------------------------------------------------------------------------------------------------------------------------------------------------------

CE: continuing education in genetics. [Table 9](#T9){ref-type="table"}. Genomic Medicine Education and Resources: Significant Results from Binary Logistic Regression Analysis

Discussion {#s4}
==========

This study offers a comprehensive view of FPs'involvement, confidence, attitudes, and resources needed in GM. The vast majority of participating FPs reported that key tasks in the delivery of traditional GM (eliciting family history, identifying patients with a genetic condition, deciding who should be offered genetic referral, knowing where to refer) were part of their current practice. The concern is that their confidence in these tasks was low. Fewer than half were confident in eliciting FH and knowing who to refer. There was a weak positive correlation between knowledge and confidence. Those who indicated they had continuing education in genetics in the past 5 years had significantly increased confidence in a number of GM skills. This lack of confidence has been shown in many studies spanning almost two decades ([@B52]; [@B26]; [@B9]; [@B39]; [@B12]; [@B36]; [@B49]; [@B16]) Fewer than 2/3 of participants in our study reported that evaluating or discussing genetic tests was part of their current practice. This is similar to a recent US study of PCPs where only 19% had ordered genetic testing, and 18% had consulted with a genetic counselor in the past 6 months, most frequently for cancer risk testing and prenatal testing. ([@B16]) Many genetic tests are already in the primary care domain and with new advances in GM, it is likely more will be available to PCPs. It is also likely that limited genetics resources (e.g. genetics clinics with long wait times), and few genetic specialists and counselors, will push more genetic testing into PC practice and that genetics specialists will be looking to their PCP colleagues to take a bigger role in pre-test counseling and assessment.

Attitudes regarding GM were mixed. Over half the respondents agreed that GM is going to make important contributions to diagnosis and management and will improve health outcomes. However fewer than half (41%) of the responding FPs agreed there are sufficient benefits to warrant testing for inherited adult onset diseases, and were even less convinced that it was their responsibility to incorporate genomics into practice (26%). The literature is mixed in this regard with some reporting cautiously optimistic attitudes about genetic testing, citing its value for risk stratification, and that testing is likely to have impact on clinical practice in the future, ([@B36]; [@B37]; [@B16]) and others expressing caution about the role of FPs in clinical genetics ([@B38]) and wanting more evidence of clinical utility ([@B36]). It is interesting that an interest in genetics was predictive of "positive" attitudes to GM, needing to keep up to date and incorporate GM into practice.

Our findings regarding some of the newer areas of GM are similar to those found in the literature. Not surprisingly, emerging areas such as pharmacogenetics, direct-to-consumer genetic testing, and whole genome sequencing were less likely to be part of current practice and confidence in these areas was low. Haga's study of PCPs showed that most (73%) had heard of pharmacogenomics and anticipated its value in informing drug response (65%) ([@B27]), however only 13% felt well-informed and 67% were uncomfortable ordering a pharmacogenetic test. This study concluded that "primary care practitioners envision a major role for themselves in the delivery of pharmacogenomic testing but recognize their lack of adequate knowledge and experience about these tests," ([@B27]) very similar to how providers see GM generally. A similar situation exists for direct-to-consumer genetic testing. Health care providers report low awareness and experience of direct-to-consumer genetic testing ([@B3]; [@B47]; [@B25]; [@B14]; [@B15]), however, many believe it will be helpful in patient management ([@B3]; [@B44]; [@B45]). In Powell's survey of PCPs, of 39% who were aware of direct-to-consumer genetic testing, 43% thought it was clinically useful. The majority (85%) were unprepared to answer patient questions and 74% wanted to learn more. ([@B44]; [@B45]) This is in contrast to a study of academic FPs who were concerned that direct-to-consumer genetic tests might cause more harm than benefit. ([@B36]) Many patients however, plan to share their personalized genomic test results with their PCP ([@B53]) and report satisfaction with that encounter if they perceive that the PCP understands genetics and is willing to discuss test results. ([@B53])

Addressing system issues has been highlighted as important to successful integration of genomics into primary care practice. ([@B38]; [@B37]; [@B18]) Less than a quarter of participating FPs indicated they could find information about genetics and available genetic testing, although encouragingly, most knew where to refer for genetic disorders. Fewer than half contacted their local genetics clinic for information, the majority used various internet resources. These findings speak to the challenge of educational initiatives, the need to enable providers to assess when genomic testing offers added value and will change patient outcomes ([@B37]; [@B18]), and the need to strengthen the relationships between genetic centers and the PC community in order to make GM services more accessible.

Increasing skills and confidence in taking a FH should be a key priority for medical education at all levels. Family history is still relevant in the genomic era as it is key to risk assessment, informing appropriate screening, and identifying those who may benefit from genetics consultation. ([@B51]; [@B21]; [@B46]; [@B35]) Opportunities should be sought to build on existing knowledge and skills in eliciting FH, to frame GM as part of ongoing skill development, not a specialized area of medicine dealing with "rare" diseases. ([@B6]) Development of FH tools suitable for primary care, that are integrated into the EHR with clinical decision support, may facilitate this.

More efforts are needed to develop both effective education and practice strategies to enable PCPs to integrate GM into primary care. This needs assessment builds on existing literature to provide direction to educational initiatives. Core competencies in genetics for non-genetics health professionals have been proposed ([@B8]; [@B51]; [@B32]; [@B37]; [@B35]) including taking a FH, risk assessment, when and how to order genetic tests, interpretation, pharmacogenetics, ethical dilemmas and psychosocial effects related to genetics, and insight into the organization and role of clinical genetics services ([@B29]). Clearly the FPs in our study identified taking FH, knowing who to refer and supporting patients who received genetic results as their current role, suggesting that educational and practice strategies should focus in these areas. Our results would suggest that newer educational methods such as podcasts and web-based tools may be more appealing to younger physicians. There are limited studies of educational interventions in GM showing mixed effectiveness. ([@B50]) They include studies of interactive web-based curricula and educational modules ([@B4]; [@B5]; [@B32]; [@B2]; [@B33]; [@B41]; [@B48]; [@B43]), FH and clinical support programs ([@B34]), point-of-care tools and decision support ([@B12]; [@B13]), and push reflective e-learning ([@B15]). Several websites exist with genomics information and on-line educational programs for PCPs (GECKO [www.geneticseducation.ca](www.geneticseducation.ca); Genetics in Primary Care Institute <https://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/Pages/Genetics-in-Primary-Care-Institute.aspx>; Genomics Education Programme, [www.genomicseducation.hee.nhs.uk](www.genomicseducation.hee.nhs.uk); The Jackson Laboratory, <https://www.jax.org/education-and-learning/clinical-and-continuing-education>; Genetics/Genomics Competency Centre, [www.g-2-c-2.org](www.g-2-c-2.org); Gen-Equip programme, [www.primarycaregenetics.org](www.primarycaregenetics.org)). A recent systematic review of interventions providing genetics education for PCPs highlights some of the challenges in this area and the need for evaluation of educational initiatives to include changes in practice to see if they are effective in improving patient management. ([@B42]) Generally, initiatives using effective continuing education strategies (interactive, case-based, skill focused, sequential reinforced learning) have been most successful. ([@B43])

The abundance of studies over the past decade demonstrating a continued lack of knowledge and confidence in GM among PCPs shows that education alone is not sufficient. As Feero says "Available studies suggest that development and maintenance of freely available high-quality genomics reference and educational materials is likely insufficient to ensure a meaningful increase in genomics competency among non-geneticist health providers." ([@B24]) Among the cultural and infrastructure changes he recommends are efforts to address the usability of EHR to manage and interpret genomic information and the time/cost burden in practice. Burke has also addressed the slow introduction of personal genomics into practice. ([@B7]) She describes several factors that contribute to "this translational gap between knowledge and clinical application" including an evidence deficit to support the use of some genetic tests, lack of clinical education and decision support for health care providers, and inflated expectations of the clinical benefit of GM, particularly in managing chronic complex diseases. She suggests using the principles of implementation science "which focuses on identifying and overcoming barriers associated with deploying and tailoring new interventions" as a means to address the gap between testing capability and practice, in those cases where evidence of utility is clear. ([@B7])

Our findings suggest that PCPs are open to changes in practice to facilitate GM. Over half our respondents thought that a telephone/fax/email helpline to a local genetic counselor or a "buddy system" where a designated geneticist was available to answer questions, would help them integrate GM into their practices. There is an emerging literature exploring how this might happen. ([@B1]; [@B32]; [@B37]; [@B18]) One such model used tailored genetics education outreach delivered by a genetic counselor to general practices over 1 year, including genetic update sessions, a responsive advice service, and referral guidelines. This service was evaluated positively by participants with continued utilization of the genetic counselor for advice following completion. ([@B22]) This type of model requires clinician acceptance and "reconfiguration of professional roles and responsibilities." ([@B1]) Interestingly, the idea of a FP or nurse with a special interest in genetics in the clinic or a visiting genetic counselor to consult in the practice was less popular among our respondents. This may be due to the relative rarity of genetic conditions in primary care. Access to a genetics specialist has been positively associated with use of genetic testing for disease diagnosis or susceptibility, however many PCPs report they do not have access to genetics expertise. ([@B28]) It may be as Haga postulates that "access for some PCPs may be effectively limited if they are unfamiliar with these experts or have not had any clinical occasion to consult them." Perhaps there is a role for counseling by phone, telemedicine or electronic consultation to enhance communication and contact. ([@B28]) As a result of this study, we developed a website containing evidence-based resources, including point-of-care tools, on GM for PCPs with clear information about how to access local genetic services ([www.geneticseducation.ca](www.geneticseducation.ca)). We are also exploring electronic consultation, questions directed to clinical geneticists by PCPs over a secure electronic platform, with response within 7--10 days, as a means for seeking clarification or guidance regarding clinical care in GM.

Limitations {#s5}
===========

The main limitation to this study was the low response rate, bringing into question the generalizability of the results. Compared to the 2013 National Physician Survey in Canada (closest in time to the study), our study respondents were of similar age (median age 51 this study, 52 National Physician Survey), higher proportion female (47%/40%), slightly lower EMR use (74%/78%), and similar likelihood to be paid through an alternative funding arrangement rather than fee for service (49%/51%). ([@B17]) This implies some similarity of our sample to Canadian FPs. Study respondents were very similar in age distribution to non-respondents. This study had more female respondents than non-respondents (respondents 47% female, non-respondents 40% female). The random sample of 100 non-respondents that we contacted in order to adjust our response rate was 39% female, similar to our overall non-responder rate. The age distribution of the sample of 100 non-respondents was similar to the overall non-respondents. The low response rate may have been due to the length of the survey, possibly suggesting that those with more interest or knowledge of GM completed the survey. If this is the case, our results raise even more questions regarding FPs' assessment of the clinical value of genetic tests and their readiness to incorporate GM into busy primary care practices. This study was conducted in one province in Canada, so its generalizability to PCPs in other countries is unknown.

Conclusions {#s6}
===========

This study shows that FPs see a role for themselves in taking FH, identifying individuals with a genetic condition, making appropriate referrals and supporting patients following genetic test results. They continue to lack the knowledge and confidence in GM skills needed for practice, particularly in the emerging areas of GM. They are somewhat optimistic about the contribution GM may make to patient care, but express caution about its current clinical benefits. Our study suggests that there is a need for more evidence of clinical utility of genetic tests, educational resources which can be integrated into primary care practice, clinical decision supports, and improved communication with genetic specialists. Resources need to include the basic skills for delivering GM (e.g. referral guidelines and testing criteria) as well as the advancing areas of pharmacogenetics, direct-to-consumer genetic testing, and whole genome sequencing.
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